Literature DB >> 19858093

Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor.

Suk-Kyeong Jung1, Dae Gwin Jeong, Sang J Chung, Jae Hoon Kim, Byoung Chul Park, Nicholas K Tonks, Seong Eon Ryu, Seung Jun Kim.   

Abstract

Eya proteins are transcription factors that play pivotal roles in organ formation during development by mediating interactions between Sine Oculis (SO) and Dachshund (DAC). Remarkably, the transcriptional activity of Eya proteins is regulated by a dephosphorylating activity within its Eya domain (ED). However, the molecular basis for the link between catalytic and transcriptional activities remains unclear. Here we report the first description of the crystal structure of the ED of human Eya2 (ED-Eya2), determined at 2.4-A resolution. In stark contrast to other members of the haloacid dehalogenase (HAD) family to which ED-Eya2 belongs, the helix-bundle motif (HBM) is elongated along the back of the catalytic site. This not only results in a structure that accommodates large protein substrates but also positions the catalytic and the SO-interacting sites on opposite faces, which suggests that SO binding is not directly affected by catalytic function. Based on the observation that the DAC-binding site is located between the catalytic core and SO binding sites within ED-Eya2, we propose that catalytic activity can be translated to SO binding through DAC, which acts as a transcriptional switch. We also captured at two stages of reaction cycles-acyl-phosphate intermediate and transition state of hydrolysis step, which provided a detailed view of reaction mechanism. The ED-Eya2 structure defined here serves as a model for other members of the Eya family and provides a framework for understanding the role of Eya phosphatase mutations in disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858093      PMCID: PMC4048942          DOI: 10.1096/fj.09-143891

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  40 in total

Review 1.  Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

Authors:  Zhong-Yin Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  Mutations of a human homologue of the Drosophila eyes absent gene (EYA1) detected in patients with congenital cataracts and ocular anterior segment anomalies.

Authors:  N Azuma; A Hirakiyama; T Inoue; A Asaka; M Yamada
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

3.  Identification of five novel BOR mutations in human EYA1 gene associated with branchio-oto-renal syndrome by a DHPLC-based assay.

Authors:  V Migliosi; E Flex; V Guida; A Martini; N Giarbini; T Markova; I Torrente; B Dallapiccola
Journal:  Clin Genet       Date:  2004-11       Impact factor: 4.438

Review 4.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

5.  Detecting and overcoming crystal twinning.

Authors:  T O Yeates
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

6.  Impaired interactions between mouse Eyal harboring mutations found in patients with branchio-oto-renal syndrome and Six, Dach, and G proteins.

Authors:  Hidenori Ozaki; Yoko Watanabe; Keiko Ikeda; Kiyoshi Kawakami
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

7.  Crystal structures of intermediates in the dehalogenation of haloalkanoates by L-2-haloacid dehalogenase.

Authors:  I S Ridder; H J Rozeboom; K H Kalk; B W Dijkstra
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

8.  A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family.

Authors:  S Abdelhak; V Kalatzis; R Heilig; S Compain; D Samson; C Vincent; D Weil; C Cruaud; I Sahly; M Leibovici; M Bitner-Glindzicz; M Francis; D Lacombe; J Vigneron; R Charachon; K Boven; P Bedbeder; N Van Regemorter; J Weissenbach; C Petit
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

9.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

10.  Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent.

Authors:  Navasona Krishnan; Dae Gwin Jeong; Suk-Kyeong Jung; Seong Eon Ryu; Andrew Xiao; C David Allis; Seung Jun Kim; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

View more
  21 in total

Review 1.  Multiple Functions of the Eya Phosphotyrosine Phosphatase.

Authors:  Ilaria Rebay
Journal:  Mol Cell Biol       Date:  2015-12-14       Impact factor: 4.272

2.  The Legionella pneumophila effector Ceg4 is a phosphotyrosine phosphatase that attenuates activation of eukaryotic MAPK pathways.

Authors:  Andrew T Quaile; Peter J Stogios; Olga Egorova; Elena Evdokimova; Dylan Valleau; Boguslaw Nocek; Purnima S Kompella; Sergio Peisajovich; Alexander F Yakunin; Alexander W Ensminger; Alexei Savchenko
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

3.  Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.

Authors:  Aaron B Krueger; David J Drasin; Wendy A Lea; Aaron N Patrick; Samarjit Patnaik; Donald S Backos; Christopher J Matheson; Xin Hu; Elena Barnaeva; Michael J Holliday; Melanie A Blevins; Tyler P Robin; Elan Z Eisenmesser; Marc Ferrer; Anton Simeonov; Noel Southall; Philip Reigan; Juan Marugan; Heide L Ford; Rui Zhao
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

Review 4.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

5.  Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity.

Authors:  Aaron B Krueger; Seameen J Dehdashti; Noel Southall; Juan J Marugan; Marc Ferrer; Xueni Li; Heide L Ford; Wei Zheng; Rui Zhao
Journal:  J Biomol Screen       Date:  2012-07-20

6.  Chronophin dimerization is required for proper positioning of its substrate specificity loop.

Authors:  Christian Kestler; Gunnar Knobloch; Ingrid Tessmer; Elisabeth Jeanclos; Hermann Schindelin; Antje Gohla
Journal:  J Biol Chem       Date:  2013-12-14       Impact factor: 5.157

Review 7.  The SIX1-EYA transcriptional complex as a therapeutic target in cancer.

Authors:  Melanie A Blevins; Christina G Towers; Aaron N Patrick; Rui Zhao; Heide L Ford
Journal:  Expert Opin Ther Targets       Date:  2015-01-02       Impact factor: 6.902

8.  Structural and functional analysis of the phosphoryl transfer reaction mediated by the human small C-terminal domain phosphatase, Scp1.

Authors:  Mengmeng Zhang; June Liu; Youngjun Kim; Jack E Dixon; Samuel L Pfaff; Gordon N Gill; Joseph P Noel; Yan Zhang
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

9.  EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study.

Authors:  Parvaneh Nikpour; Modjtaba Emadi-Baygi; Elaheh Emadi-Andani; Shima Rahmati
Journal:  Med Oncol       Date:  2014-04-12       Impact factor: 3.064

Review 10.  The Eya phosphatase: Its unique role in cancer.

Authors:  Hengbo Zhou; Lingdi Zhang; Rebecca L Vartuli; Heide L Ford; Rui Zhao
Journal:  Int J Biochem Cell Biol       Date:  2017-09-05       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.